We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » California and Illinois Bills Take Opposite Approach to Biosimilar Substitution
California and Illinois Bills Take Opposite Approach to Biosimilar Substitution
Two state legislatures are considering biosimilar substitution bills, but are taking opposite approaches to the issues of prescriber notification and patient consent.